Why Bionano Genomics Stock Skyrocketed More Than 100% Today

Shares of Bionano Genomics (NASDAQ: BNGO) soared on Monday after the genome analysis company published a study on autism-risk genes. As of 1:50 p.m. EST today, Bionano's stock price was up 115%.

Bionano announced that its diagnostic services subsidiary, Lineagen, completed a comprehensive analysis of a single genome of a high-functioning individual with Autism Spectrum Disorder (ASD). Lineagen's genetic tests identified novel variants in known ASD risk genes and other genetic variants in the subject, which Bionano believes could help to improve healthcare outcomes.

Image source: Getty Images.

Continue reading

Source Fool.com